Back to Walleye Capital LLC Walleye Capital LLC

ALPNALPN
11 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in ALPINE IMMUNE SCIENCES INC

Walleye Capital LLC previously held 0 shares of ALPN (ALPINE IMMUNE SCIENCES INC), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.5M

Total Shares Change

-110,099

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q1
Decreased
206,104
-43.7%
$8.2M0.0%
0
2023-Q4
Increased
365,940
+96.5%
$7M0.0%
44
2023-Q3
Increased
186,273
+13.1%
$2.1M0.0%
29
2023-Q2
Increased
164,673
+382.7%
$1.7M0.0%
41
2023-Q1
New
34,117
-
$263,3830.0%
32
2022-Q4
Exited
0
-100.0%
$00.0%
0
2022-Q3
New
71,355
-
$514,0000.0%
33
2022-Q2
Exited
0
-100.0%
$00.0%
0
2022-Q1
Decreased
41,746
-62.1%
$374,0000.0%
0
2021-Q4
New
110,099
-
$1.5M0.0%
35

Other major holders of ALPN: Avoro Capital Advisors LLC, BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used